Michael Baram, MD
Professor of Medicine
Director of Post-ICU Clinic
Director of Clinical ICU Trials
Contact
834 Walnut Street
Suite 650
Philadelphia, PA 19107
215-955-6591
215-955-0830 fax
Michael Baram, MD
Professor of Medicine
Director of Post-ICU Clinic
Director of Clinical ICU Trials
Education
Medical School
Jefferson Medical College
Residency
Christiana Care Health System
Fellowship
Rhode Island Hospital
Publications
- The Discover In-Hospital Cardiac Arrest (Discover IHCA) Study: An Investigation of Hospital Practices After In-Hospital Cardiac Arrest
- Observational study of the effect of ketamine infusions on sedation depth, inflammation, and clinical outcomes in mechanically ventilated patients with SARS-CoV-2
- Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome
- Outcomes of extracorporeal membrane oxygenation in immunosuppressed vs. Immunocompetent patients
- SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution
Board Certification
Internal Medicine
Pulmonary Disease
Critical Care Medicine
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
University Appointment
Professor of Medicine
Research & Clinical Interests
Michael Baram is a Jefferson Medical College graduate. He completed his residency in Internal Medicine and Emergency at Christiana Care Health system, an affiliated medical center that provides medical care to all of Delaware as well as surrounding states. He then completed Fellowship at Brown University in Pulmonary and Critical Care Medicine. Dr. Baram currently clinically works as an Intensivist at Jefferson Hospital, in center city Philadelphia. His major non-clinical responsibility is Director of the Pulmonary and Critical Care Training Program.
With Dr. Baram's background in Emergency Medicine, his interest is acute care of the critically ill. Research projects have included national studies involving sepsis and septic shock, such as Prowess-Shock and Euphrates. He has been involved in International projects such as the surviving sepsis campaign. In areas of sepsis and shock he has worked with various medications for sepsis, hemodynamic monitoring, and ultrasound training. Another area of interest is acute respiratory failure (ARDS) that requires advanced modes of ventilation beyond the recommendations of ARDSnet. Some of these modes include APRV, BiLevel, inhaled epoprostanol, and ECMO. In tight coordination with cardiac surgery, Jefferson has a robust ECMO program for ventilating and oxygenating the critically ill.